Brief: Bruker Announces Majority Investment In MIMETAS To Advance Human Physiology-Relevant Drug Discovery And Development
BRIEF-Bruker Announces Majority Investment In MIMETAS To Advance Human Physiology-Relevant Drug Discovery And Development Aug 10 (Reuters) - Bruker Corporation BRKR.O:
BRUKER ANNOUNCES MAJORITY INVESTMENT IN MIMETAS TO ADVANCE HUMAN PHYSIOLOGY-RELEVANT DRUG DISCOVERY AND DEVELOPMENT
BRUKER CORPORATION - FINANCIAL DETAILS NOT DISCLOSED; MIMETAS TO OPERATE UNDER EXISTING BRAND AND MANAGEMENT
BRUKER CORPORATION - MIMETAS PROVIDES SCALABLE ORGAN-ON-A-CHIP SOLUTIONS FOR HUMAN-RELEVANT TISSUES
Source text: ID:nBwb7YP8xa
Further company coverage: BRKR.O
((Reuters.Briefs@thomsonreuters.com;))